image
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 3.58
-6.77 %
$ 251 M
Market Cap
-3.11
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one HCAT stock under the worst case scenario is HIDDEN Compared to the current market price of 3.58 USD, Health Catalyst, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one HCAT stock under the base case scenario is HIDDEN Compared to the current market price of 3.58 USD, Health Catalyst, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one HCAT stock under the best case scenario is HIDDEN Compared to the current market price of 3.58 USD, Health Catalyst, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart HCAT

image
$10.0$10.0$9.0$9.0$8.0$8.0$7.0$7.0$6.0$6.0$5.0$5.0$4.0$4.0$3.0$3.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
307 M REVENUE
3.60%
-69.8 M OPERATING INCOME
44.99%
-69.5 M NET INCOME
41.17%
14.6 M OPERATING CASH FLOW
144.01%
-22.9 M INVESTING CASH FLOW
-112.86%
152 M FINANCING CASH FLOW
5458.46%
79.6 M REVENUE
4.26%
-17.5 M OPERATING INCOME
-27.86%
-20.7 M NET INCOME
-40.38%
-3.53 M OPERATING CASH FLOW
-56.81%
-113 M INVESTING CASH FLOW
-1474.61%
37.7 M FINANCING CASH FLOW
2514.48%
Balance Sheet Health Catalyst, Inc.
image
Current Assets 466 M
Cash & Short-Term Investments 392 M
Receivables 57.2 M
Other Current Assets 16.5 M
Non-Current Assets 393 M
Long-Term Investments 0
PP&E 41.5 M
Other Non-Current Assets 352 M
45.64 %6.66 %4.83 %40.96 %Total Assets$858.9m
Current Liabilities 326 M
Accounts Payable 11.4 M
Short-Term Debt 235 M
Other Current Liabilities 79.6 M
Non-Current Liabilities 168 M
Long-Term Debt 16.3 M
Other Non-Current Liabilities 152 M
47.56 %16.13 %3.30 %30.70 %Total Liabilities$493.7m
EFFICIENCY
Earnings Waterfall Health Catalyst, Inc.
image
Revenue 307 M
Cost Of Revenue 166 M
Gross Profit 141 M
Operating Expenses 211 M
Operating Income -69.8 M
Other Expenses -304 K
Net Income -69.5 M
350m350m300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)307m(166m)141m(211m)(70m)304k(70m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
45.92% GROSS MARGIN
45.92%
-22.77% OPERATING MARGIN
-22.77%
-22.67% NET MARGIN
-22.67%
-19.03% ROE
-19.03%
-8.09% ROA
-8.09%
-9.13% ROIC
-9.13%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Health Catalyst, Inc.
image
20m20m10m10m00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)2018201820192019202020202021202120222022202320232024202420252025
Net Income -69.5 M
Depreciation & Amortization 41.4 M
Capital Expenditures -1.62 M
Stock-Based Compensation 40.1 M
Change in Working Capital -660 K
Others -7.44 M
Free Cash Flow 12.9 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Health Catalyst, Inc.
image
Wall Street analysts predict an average 1-year price target for HCAT of $8.57 , with forecasts ranging from a low of $5 to a high of $14 .
HCAT Lowest Price Target Wall Street Target
5 USD 39.66%
HCAT Average Price Target Wall Street Target
8.57 USD 139.43%
HCAT Highest Price Target Wall Street Target
14 USD 291.06%
Price
Max Price Target
Min Price Target
Average Price Target
14141212101088664422Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 10
6. Ownership
Insider Ownership Health Catalyst, Inc.
image
Sold
0-3 MONTHS
226 K USD 3
3-6 MONTHS
826 K USD 6
6-9 MONTHS
258 K USD 5
9-12 MONTHS
311 K USD 5
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025 SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2025 operating results on Wednesday, May 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. globenewswire.com - 2 weeks ago
Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025 AI-driven healthcare companies like Butterfly Network and Health Catalyst have all the qualities to emerge as the next big players. zacks.com - 3 weeks ago
Health Catalyst Releases Data and Analytics Solution Designed for Community, Regional, and Specialty Health Systems: Health Catalyst Ignite Spark™ SALT LAKE CITY , April 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Health Catalyst Ignite Spark™, a tailored data and analytics solution built for community health systems, regional hospitals, and multi-site practices. Smaller community health systems across the U.S. are navigating shrinking margins, policy uncertainty, and rising pressure to deliver more with less. prnewswire.com - 3 weeks ago
Health Catalyst: Share Price Continues To Dismiss Positive Earnings And Improved Outlook Despite a 50% drop in HCAT's stock price, the company shows significant growth, reporting $307M in revenue and $26M in adjusted EBITDA for 2024. Health Catalyst focuses on efficiency, exiting lower-margin segments, and pushing AI-driven efficiencies, aiming for improved margins and profitability in 2025. The company forecasts strong growth with 40 new platform clients in 2025 and expects $335M in revenue, trading at a significant discount compared to industry peers. seekingalpha.com - 1 month ago
Is the Options Market Predicting a Spike in Health Catalyst (HCAT) Stock? Investors need to pay close attention to Health Catalyst (HCAT) stock based on the movements in the options market lately. zacks.com - 1 month ago
Health Catalyst Announces ~$5 Million Stock Repurchase SALT LAKE CITY , March 11, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has repurchased shares of its common stock ("Common Stock") in an aggregate amount of approximately $5 million. These repurchased shares were acquired between March 3, 2025, and March 10, 2025, as part of Health Catalyst's existing share repurchase program approved by its board of directors on August 2, 2022, which authorized repurchases of up to $40 million of Common Stock. prnewswire.com - 1 month ago
Signature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™ SALT LAKE CITY , Feb. 27, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year agreement with Signature Healthcare, an integrated healthcare delivery system serving Southeastern Massachusetts. Signature Healthcare is collaborating with Health Catalyst to integrate data resource queries and unlock referral-related data powered by Health Catalyst Ignite™, a modern data and analytics ecosystem. prnewswire.com - 2 months ago
Health Catalyst, Inc. (HCAT) Q4 2024 Earnings Call Transcript Health Catalyst, Inc. (NASDAQ:HCAT ) Q4 2024 Earnings Call Transcript February 26, 2025 5:00 PM ET Company Participants Jack Knight - Vice President, Investor Relations Dan Burton - Chief Executive Officer Dan LeSueur - Chief Operating Officer Jason Alger - Chief Financial Officer Conference Call Participants Jared Haase - William Blair Anne Samuel - JPMorgan Jessica Tassan - Piper Sandler Sameer Patel - Evercore ISI John Pinney - Canaccord Genuity Daniel Grosslight - Citi David Larsen - BTIG Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Operator Welcome to the Health Catalyst's Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation. seekingalpha.com - 2 months ago
Compared to Estimates, Health Catalyst (HCAT) Q4 Earnings: A Look at Key Metrics Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 2 months ago
Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.02 per share a year ago. zacks.com - 2 months ago
Health Catalyst Reports Fourth Quarter and Year End 2024 Results SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2024. globenewswire.com - 2 months ago
Health Catalyst to Participate in Upcoming Investor Conference SALT LAKE CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the Raymond James & Associates' 46th Annual Institutional Investors Conference, in Orlando, FL. Health Catalyst will host a fireside chat presentation on Tuesday, March 4, 2025, at 1:40 p.m. globenewswire.com - 2 months ago
8. Profile Summary

Health Catalyst, Inc. HCAT

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 251 M
Dividend Yield 0.00%
Description Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
Contact 10897 South River Front Parkway, South Jordan, UT, 84095 https://www.healthcatalyst.com
IPO Date July 25, 2019
Employees 1500
Officers Ms. Amanda Flanders Senior Vice President of Marketing & Communications Mr. Benjamin Landry General Counsel & Secretary of the Board Mr. Kyle J. Salyers Chief Strategy Officer & Senior Vice President of Corporate Development Mr. Daniel LeSueur Chief Operating Officer Mr. Dave Ross Chief Technology Officer Mr. Jeffrey P. Selander Senior Vice President of International Mr. Daniel D. Burton Chief Executive Officer & Director Ms. Linda Llewelyn Chief People Officer Mr. Jason Alger Chief Financial Officer Ms. Holly Rimmasch Senior Vice President & Chief Clinical Officer